Buy Eli Lilly While The Market Hesitates And Let Time Make You Dominate
Summary
Eli Lilly is positioned for a 30-50% return in the next 12 months based on a nexus of value and growth. While others hes...
Eli Lilly is positioned for a 30-50% return in the next 12 months based on a nexus of value and growth. While others hesitate on greatness, I buy at the prices everyone else wishes they did. Risks are the price of admission to elite returns. No champion in the market rises without scar tissue.
Related Articles
Lilly's Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer's disease
LLY
Positive3 Dividend Growth Stocks You Can Buy and Forget About
LLY
PositiveLilly sees obesity drug leadership beyond US as it leans on consumer-focused strategy
LLY
Neutral